Bassem Saleh has been appointed new CEO of TFS. Bassem is Chief Medical Officer at TFS and Executive Vice President of Clinical Development Services, the largest Business Area at TFS. He will assume his role as CEO today, 17 December. János Filakovský is stepping down from his position as CEO and leaving the company.
Bassem Saleh has solid executive leadership skills and long industry experience from both CROs (Contract Research Organisations) and Biopharma including Premiere Research, ICON, PRAHS and Chugai (Roche group). Most recently Bassem has been heading up TFS largest Business Area Clinical Development Services (CDS) with strong results and is an appreciated leader in the company. Bassem is a medical doctor specialized in Pharmaceutical Medicine and Oncology.
“Bassem has impressed the board of TFS with the results he has delivered in the business. He is an appreciated leader at TFS and with his background from the industry we believe he is an ideal person to further develop TFS as CEO. We thank János for his contributions to TFS,” says Jonas Wiström, CEO of Ratos and Business Area President Industry.
Ratos became an owner of TFS in 2015. On behalf of its customers, the company conduct clinical trials in more than 40 countries worldwide and works with a broad international customer base of leading research companies. Revenues for the rolling 12 months at 30 September 2019 amounted to 86.0 MEUR and EBITA was 1.8 MEUR.
For further information, please contact:
Jonas Wiström, President and CEO, Ratos, +46 8 700 17 00
Per Magnusson, Chairman TFS and Director Operations, Ratos, +46 70 676 64 26
Helene Gustafsson, Head of IR and Press, Ratos, +46 70 868 40 50